Biocept's SR VP of R&D and CSO just picked up 45,000 shares

Lyle J Arnold, Biocept's SR VP of R&D and CSO, recently acquired 45,000 shares of the company. The buys took place at $1.10 per share, on October 19, 2016. Arnold now owns 65,238 shares of the company. Arnold operates out of San Diego, CA. Some additional info was provided as follows:

Shares were purchased from the issuer in a unit offering, with each unit consisting of one share of Common Stock and one warrant to purchase one share of Common Stock for $1.10 per unit. On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 40,476 fewer shares.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Biocept makes a similar move, sign up!

Other recent filings from the company include the following:

Biocept director just picked up 5,667 shares - March 29, 2017
Biocept just filed a prospectus, suggesting it plans to soon issue some securities - March 29, 2017
Biocept Just Filed Its Annual Report: 12. Net Loss per Co... - March 28, 2017
Shareholder Director - March 23, 2017
CFO of Biocept was just granted 16,383 options - March 22, 2017

Auto Refresh

Feedback